Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
ConclusionPatients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the COVID-19. On the other hand, COVID-19 can, in turn, aggravate the damage to the heart.
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | China Health | COVID-19 | Diabetes | Endocrinology | Heart | Hypertension | Study